X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (418) 418
Book Review (64) 64
Publication (36) 36
Book Chapter (10) 10
Conference Proceeding (5) 5
Dissertation (4) 4
Magazine Article (3) 3
Book / eBook (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gleevec (308) 308
index medicus (286) 286
imatinib mesylate (252) 252
humans (245) 245
benzamides (190) 190
imatinib (138) 138
male (100) 100
oncology (100) 100
chronic myeloid-leukemia (94) 94
chronic myelogenous leukemia (88) 88
pyrimidines - therapeutic use (86) 86
animals (83) 83
piperazines - therapeutic use (83) 83
antineoplastic agents - therapeutic use (81) 81
female (78) 78
pyrimidines - pharmacology (75) 75
piperazines - pharmacology (69) 69
cancer (66) 66
middle aged (61) 61
protein-tyrosine kinases - antagonists & inhibitors (58) 58
leukemia (55) 55
tyrosine kinase inhibitor (55) 55
adult (54) 54
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (54) 54
antineoplastic agents - pharmacology (53) 53
bcr-abl (53) 53
pharmacology & pharmacy (53) 53
sti571 (53) 53
aged (51) 51
tyrosine kinase (49) 49
cell line, tumor (48) 48
c-kit (46) 46
chronic myeloid leukemia (46) 46
mice (45) 45
gastrointestinal stromal tumor (41) 41
glivec (39) 39
sti-571 (36) 36
antineoplastic agents (35) 35
gastrointestinal stromal tumors (35) 35
piperazines - adverse effects (34) 34
pyrimidines - adverse effects (34) 34
antimitotic agents (33) 33
antineoplastic agents - adverse effects (33) 33
chemistry, analytical (33) 33
in-vitro (33) 33
biochemistry & molecular biology (32) 32
hematology (32) 32
imatinib mesylate gleevec (32) 32
apoptosis (31) 31
care and treatment (31) 31
cell biology (31) 31
research (31) 31
therapy (30) 30
tumors (30) 30
mesylate (29) 29
pyrimidines - administration & dosage (29) 29
inhibitor (28) 28
philadelphia-chromosome (28) 28
piperazines - administration & dosage (28) 28
resistance (28) 28
gist (27) 27
abl tyrosine kinase (26) 26
analysis (26) 26
growth (26) 26
biochemical research methods (25) 25
drug st1571 gleevec (25) 25
protein kinase inhibitors - therapeutic use (25) 25
quantification (25) 25
cells (24) 24
protein kinase inhibitors - pharmacology (24) 24
cml (23) 23
gastrointestinal stromal tumors - drug therapy (23) 23
immunohistochemistry (23) 23
tandem mass-spectrometry (23) 23
cell proliferation - drug effects (22) 22
dose-response relationship, drug (22) 22
drug resistance, neoplasm (22) 22
mutation (22) 22
pharmacokinetics (22) 22
pyrimidines - pharmacokinetics (22) 22
signal transduction (22) 22
treatment outcome (22) 22
tyrosine (22) 22
antineoplastic agents - administration & dosage (21) 21
chemotherapy (21) 21
expression (21) 21
pyrimidines - blood (20) 20
surgery (20) 20
apoptosis - drug effects (19) 19
drug therapy (19) 19
hemic and lymphatic diseases (19) 19
medicine & public health (19) 19
pathology (19) 19
piperazines - blood (19) 19
piperazines - pharmacokinetics (19) 19
proteins (19) 19
biology (18) 18
gastrointestinal stromal tumors - pathology (18) 18
neoplasms - drug therapy (18) 18
acute lymphoblastic-leukemia (17) 17
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (420) 420
French (6) 6
Korean (5) 5
German (4) 4
Spanish (2) 2
Chinese (1) 1
Japanese (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2005, Volume 102, Issue 6, pp. 1992 - 1997
Journal Article
Xenobiotica, ISSN 0049-8254, 03/2016, Volume 46, Issue 3, pp. 278 - 287
Journal Article
Brazilian Journal of Pharmaceutical Sciences, ISSN 1984-8250, 2018, Volume 54, Issue 2
Gleevec (imatinib) is an antineoplastic chemotherapeutic agent used in the treatment of many types of cancer. The current study was conducted to examine the... 
Chemotherapy | Proanthocyandins | Gleevec/effects | Liver | Proliferation | Gleevec/imatinib | Apoptosis | DOXORUBICIN | P53 | AMETHOPTERIN | BCL-2 | L-CARNITINE | ANTIOXIDANT | Gleevec/Imatinib | IMATINIB | PHARMACOLOGY & PHARMACY | EXPRESSION
Journal Article
by Wang, ZX and Wu, XJ and Yang, HP and Guo, XM
BOLETIN DE MALARIOLOGIA Y SALUD AMBIENTAL, ISSN 1690-4648, 2019, Volume 59, Issue 1, pp. 126 - 131
Gastrointestinal stromal tumors are the most common mesenchymaltumors of the gastrointestinal tract, which originate in the gastrointestinal tract and... 
INFECTIOUS DISEASES | Tumor Recurrence | MesenchymalTumors | Gleevec | Targeted Therapy | PARASITOLOGY
Journal Article
AMERICAN JOURNAL OF SURGERY, ISSN 0002-9610, 12/2003, Volume 186, Issue 6, pp. 665 - 669
Background: Imatinib mesylate (Gleevec) is being studied as adjuvant chemotherapy for the treatment of cKIT+ gastrointestinal stromal tumors (GISTs). Early... 
neoadjuvant | gastrointestinal stromal tumor | KIT | Gleevec | imatinib mesylate | surgery
Journal Article
Current opinion in oncology, ISSN 1040-8746, 7/2014, Volume 26, Issue 4, pp. 415 - 421
Journal Article
Korean Journal of Dermatology, ISSN 0494-4739, 06/2015, Volume 53, Issue 5, pp. 388 - 391
Journal Article
대한피부과학회지, ISSN 0494-4739, 2015, Volume 53, Issue 5, p. 388
Imatinib mesylate (Gleevecⓡ) is a small-molecule inhibitor that selectively inhibits the tyrosine kinase family, including mutated KIT oncoproteins in... 
Psoriasis | Imatinib mesylate | Gleevec | Gastrointestinal stromal tumor
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 9/2011, Volume 50, Issue 9, pp. 551 - 603
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2011, Volume 70, Issue 6, pp. 1003 - 1009
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 02/2009, Volume 37, Issue 2, pp. 439 - 442
Journal Article